Imiquimod a new adjuvant for telomerase peptide vaccine: A phase I trial in patients with inoperable pancreatic cancer.

被引：0

作者：

Bernhardt, SL

Buanes, TA

Moller, M

Eriksen, JA

Geudernack, G

机构：

[1] Univ Oslo, Ullevaal Hosp, N-0407 Oslo, Norway

[2] Gemvax, Porsgrunn, Norway

[3] Norwegian Radium Hosp, Oslo, Norway

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：867S / 867S

页数：1

共 50 条

[31] Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients
Cusi, Maria Grazia
Botta, Cirino
Pastina, Pierpaolo
Rossetti, Maria Grazia
Dreassi, Elena
Guidelli, Giacomo Maria
Fioravanti, Antonella
Martino, Elodia Claudia
Gandolfo, Claudia
Pagliuchi, Marco
Basile, Assunta
Carbone, Salvatore Francesco
Ricci, Veronica
Micheli, Lucia
Tassone, Pierfrancesco
Tagliaferri, Pierosandro
Pirtoli, Luigi
Correale, Pierpaolo
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (09) : 1159 - 1173
[32] Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients
Maria Grazia Cusi
Cirino Botta
Pierpaolo Pastina
Maria Grazia Rossetti
Elena Dreassi
Giacomo Maria Guidelli
Antonella Fioravanti
Elodia Claudia Martino
Claudia Gandolfo
Marco Pagliuchi
Assunta Basile
Salvatore Francesco Carbone
Veronica Ricci
Lucia Micheli
Pierfrancesco Tassone
Pierosandro Tagliaferri
Luigi Pirtoli
Pierpaolo Correale
Cancer Immunology, Immunotherapy, 2015, 64 : 1159 - 1173
[33] Telomerase peptide vaccination of patients with advanced non-small cell lung cancer - A phase I-II trial
Brunsvig, P
Gjertsen, M
Kvalheim, G
Sve, I
Moller, M
Eriksen, J
Aamdal, S
LUNG CANCER, 2005, 49 : S86 - S86
[34] Phase I clinical trial with VEGFR2-epitope peptide and gemcitabine for patients with advanced pancreatic cancer
Yamaue, H.
Miyazawa, M.
Ohsawa, R.
Tani, M.
Kawai, M.
Hirono, S.
Ina, S.
Tsunoda, T.
Nakamura, Y.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[35] Phase II trial of therapeutic pancreatic cancer vaccine
不详
EXPERT REVIEW OF VACCINES, 2005, 4 (06) : 791 - 791
[36] Phase I trial of gemcitabine (Gemzar®, 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer
Oettle, H
Pelzer, U
Hochmuth, K
Diebold, T
Langrehr, J
Schmidt, CA
Arning, M
Vogl, TJ
Neuhaus, P
Huhn, D
Riess, H
ANTI-CANCER DRUGS, 1999, 10 (08) : 699 - 704
[37] Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Middleton, Gary
Silcocks, Paul
Cox, Trevor
Valle, Juan
Wadsley, Jonathan
Propper, David
Coxon, Fareeda
Ross, Paul
Madhusudan, Srinivasan
Roques, Tom
Cunningham, David
Falk, Stephen
Wadd, Nick
Harrison, Mark
Corrie, Pippa
Iveson, Tim
Robinson, Angus
McAdam, Karen
Eatock, Martin
Evans, Jeff
Archer, Caroline
Hickish, Tamas
Garcia-Alonso, Angel
Nicolson, Marianne
Steward, William
Anthoney, Alan
Greenhalf, William
Shaw, Victoria
Costello, Eithne
Naisbitt, Dean
Rawcliffe, Charlotte
Nanson, Gemma
Neoptolemos, John
LANCET ONCOLOGY, 2014, 15 (08): : 829 - 840
[38] Phase I study of peptide vaccine with chemotherapy in patients with unresectable colorectal cancer
Yoshimatsu, K.
Yokomizo, H.
Otani, T.
Osawa, G.
Ogawa, K.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[39] Phase I/II trial of carbon-ion radiotherapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer.
Shinoto, Makoto
Yamada, Shigeru
Yasuda, Shigeo
Imada, Hiroshi
Shioyama, Yoshiyuki
Honda, Hiroshi
Kamada, Tadashi
Tsujii, Hirohiko
Saisho, Hiromitsu
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[40] A phase II trial of the vitamin D analogue Seocalcitol (EB 1089) in patients with inoperable pancreatic cancer
Evans, TRJ
Colston, KW
Lofts, FJ
Cunningham, D
Anthoney, DA
Gogas, H
de Bono, JS
Hamberg, KJ
Skov, T
Mansi, JL
BRITISH JOURNAL OF CANCER, 2002, 86 (05) : 680 - 685

← 1 2 3 4 5 →